Equity
Pay-to-Play Recapitalizations: What a Cram-Down Does to Your Cap Table and Your 409A
Pay-to-play hit 8.4% of venture deals last quarter. Here is what a forced conversion to common does to your preference stack, your NOLs, and your next 409A.
By 409.AI Team - 2026-09-18
# Pay-to-Play Recapitalizations: What a Cram-Down Does to Your Cap Table and Your 409A
Pay-to-play provisions appeared in 8.4% of the venture financings Cooley handled in the second quarter of 2026, up from 7% in the first quarter. Recapitalizations ticked up too, to 1.81% of deals. Small numbers, and they climbed in a quarter that set a record for invested capital, with [$85.7 billion across 166 deals](https://www.cooley.com/news/insight/2026/2026-08-17-q2-2026-venture-financing-report). Capital is abundant at the top of the market and tight in the middle. Companies in the middle are the ones getting the pay-to-play term sheet.
If one just landed in your inbox, here is the mechanic. A pay-to-play provision requires existing preferred holders to buy their pro rata share of the new round. Pass, and your preferred converts into common. The liquidation preference goes away, and so do the protective votes, the board designee, and the anti-dilution ratchet.
Founders tend to read that as a win. The investors who stopped answering email lose their preference, the stack shrinks, and common finally gets room. Part of that is true. The rest is what catches people out: what the conversion does to your share count, what it does to your net operating losses, and why the price of the recap round might not be the number your next 409A gets built on.
Pay-to-play is not anti-dilution
These two terms get mixed up constantly, and they do opposite things.
Anti-dilution protects an investor who sits still. When you price a round below what they paid, their conversion ratio adjusts so they end up with more common shares. It costs the common stockholders, and [the difference between full ratchet and broad-based weighted average](https://www.409.ai/articles/anti-dilution-full-ratchet-weighted-average-down-round) is the difference between a painful round and a fatal one.
Pay-to-play punishes an investor who sits still. Write the check and keep your rights. Skip it and you join your employees as a common stockholder. Both provisions often ride in the same charter, which is why one recap can ratchet the participants up and strip the non-participants down at once.
The penalty is not always a clean one-for-one conversion. Punitive ratios show up in harder deals, and a 10-to-1 forced conversion leaves a holder with a tenth of the shares it would have had at 1-to-1, on top of losing its preference. That gap is why the National Venture Capital Association added non-circumvention language to its [model Certificate of Incorporation](https://nvca.org/document/nvca-model-certificate-of-incorporation-updated-oct-2025/): investors had worked out that they could convert voluntarily at 1-to-1 before the pay-to-play round closed and dodge the worse ratio entirely. The model charter now suspends the optional conversion right from the moment the company delivers notice of a qualified financing until that financing closes or terminates, a change Gibson Dunn describes as aimed at [stopping that end run](https://biotechbriefings.gibsondunn.com/the-latest-pay-to-play-non-circumvention-provisions-in-the-nvca-model-documents-and-considerations-for-private-biotech-companies/). If your charter predates that language, counsel has to add it, which takes whatever preferred vote your charter requires.
The cap table math, run all the way through
Take a company, numbers simplified, with a $40 million preference stack and a 409A from twelve months ago.
| Class | Shares | Price | Preference | |---|---|---|---| | Common and options | 10,000,000 | | none | | Series Seed | 4,000,000 | $1.00 | $4,000,000 | | Series A | 6,000,000 | $2.00 | $12,000,000 | | Series B | 8,000,000 | $3.00 | $24,000,000 | | Fully diluted | 28,000,000 | | $40,000,000 |
That 409A concluded an equity value of $48 million. Walk it down [the waterfall](https://www.409.ai/articles/liquidation-preferences-waterfall-common-stock-exit) and every series takes its preference rather than converting, leaving $8 million for 10 million common shares, or $0.80 a share on a current-value basis. The option pricing model adds time value, a discount for lack of marketability takes some back, and the report landed on $0.70.
Now the recap. The company raises $10 million of senior Series C at $0.50 a share, so 20 million new shares against the 28 million already outstanding. The pay-to-play term says participate pro rata or convert to common at 1-to-1. Holders of 12 million preferred shares decline: the whole Seed, the whole Series A, and 2 million shares of Series B. That wipes out $22 million of preference.
Here is the after picture.
| Class | Shares | Preference | |---|---|---| | Common and options | 22,000,000 | none | | Series B (participated) | 6,000,000 | $18,000,000 | | Series C (new, senior) | 20,000,000 | $10,000,000 | | Fully diluted | 48,000,000 | $28,000,000 |
Two forces now pull against each other. The preference stack fell from $40 million to $28 million, which helps common. The fully diluted count went from 28 million shares to 48 million, which hurts it. Your employees were not so much diluted by a new investor as joined by twelve million new common holders who used to sit above them in line.
Solve for the equity value at which the Series C is worth the $0.50 it just paid and you land near $18 million, well under the $24 million you get by multiplying $0.50 across all 48 million shares. The new preferred is worth more per share than the common behind it, which is why those two numbers never match.
At $18 million against a $28 million stack, common has no current value at all and carries only option value, running in the neighborhood of five cents a share on a cap table shaped like this one, once the marketability discount comes off.
So: $0.70 down to $0.05, a 93% drop, and cheap new grants for everyone who stayed. That is the outcome most founders brace for, and the one they tend to describe to their team before anyone has run the valuation.
Why the recap price may not set your 409A
The backsolve is the default tool here. You have a fresh price for one security, so you solve for the total equity value that reproduces it and allocate from there. [OPM, PWERM, and the backsolve](https://www.409.ai/articles/409a-allocation-methods-opm-pwerm-backsolve) all start from a defensible view of what the whole company is worth.
The load-bearing phrase is "arm's length." Treasury's list of factors a reasonable 409A valuation must weigh calls out values determinable through "nondiscretionary, objective means (such as through trading prices on an established securities market or an amount paid in an arm's length private transaction)" and "recent arm's length transactions involving the sale or transfer of such stock," at [Treas. Reg. 1.409A-1(b)(5)(iv)(B)](https://www.law.cornell.edu/cfr/text/26/1.409A-1). An insider-led round priced by the people who control the board, with a coercive conversion penalty attached, does not automatically qualify. AICPA cheap stock guidance treats a company's own recent transactions as evidence to be weighed against the other approaches rather than a number to be adopted, and that guidance is [being rewritten right now](https://www.409.ai/articles/aicpa-cheap-stock-guide-2026-update-409a-valuation) for the first time since 2013.
Your appraiser therefore has a real judgment call. If the recap reads as a forced transaction, the backsolve gets downweighted and a market or income approach carries more of the conclusion. Say that lands at $26 million rather than $18 million. Against the same $28 million stack, common is no longer as far out of the money, and the concluded price plausibly comes in near $0.18.
Three and a half times the strike price, from one methodological decision, on a cap table where nothing else moved.
That sensitivity is the actual lesson here. After a recap, common sits far enough out of the money to behave like a long-dated option, and option values swing hard on small changes in the underlying. Before the recap, moving equity value by $8 million would have moved common by a few cents. After it, the same $8 million triples what your next twenty hires pay.
Two things follow. Do not promise the team a penny strike before the report comes back. And do not grant anything in the gap: a recap is about as material as an event gets, the old valuation dies the moment it closes, and [granting against a stale 409A](https://www.409.ai/articles/409a-valuation-frequency-how-often-should-you-get-one) is how a safe harbor gets lost.
Options granted before the recap are a separate headache. At a $0.70 strike against a $0.05 or $0.18 fair market value, they are decoration. Repricing carries [409A, ISO, and ASC 718 consequences](https://www.409.ai/articles/down-round-409a-underwater-options-repricing) worth understanding before the board meeting rather than after.
Your NOLs are probably the expensive part
A recap like this one usually trips Section 382. It defines an ownership change as a more than 50 percentage point increase in ownership by 5-percent shareholders over a three-year testing period, and issuing 20 million shares against 28 million outstanding, plus whatever the participating insiders bought, gets there fast. Once it trips, your carryforwards are metered out annually at a rate tied to the company's value.
Read how that value is measured. "The value of the old loss corporation is the value of the stock of such corporation ... immediately before the ownership change," says [IRC 382(e)(1)](https://www.law.cornell.edu/uscode/text/26/382). Immediately before. Not before the business deteriorated, and not after the new money lands. You get the crashed number.
The new money will not rescue it either. Section 382(l)(1) disregards "any capital contribution received by an old loss corporation as part of a plan a principal purpose of which is to avoid or increase any limitation under this section," and contributions made in the two years before the change date arrive presumed to be part of such a plan. A company with $30 million of carryforwards and a $6 million pre-change value can end up entitled to use a few hundred thousand dollars of them a year. Run [the Section 382 analysis](https://www.409.ai/articles/section-382-ownership-change-startup-nol-carryforwards) before you sign, because the tax attribute you are burning is sometimes worth more than the round.
One piece of good news on QSBS
Investors converting preferred into common often assume they just reset their Section 1202 clock. Generally they did not. IRC 1202(f) provides that where stock is acquired solely through the conversion of other stock in the same corporation that was qualified small business stock in the taxpayer's hands, the new stock is treated as QSBS and is treated as held for the entire period the converted stock was held.
That is a clean answer for a conversion happening under the charter's own terms. It is not one for a restructuring that swaps in new instruments, changes economic terms, or routes through a new entity, and whether the original preferred ever qualified is its own multi-part test. Check [the current Section 1202 rules](https://www.409.ai/articles/qsbs-one-big-beautiful-bill-act-section-1202-changes) against your facts with your tax advisor rather than assuming.
The board process is what gets litigated
Insider-led cram-downs are the fact pattern Delaware courts examine hardest. In *Carsanaro v. Bloodhound Technologies*, 65 A.3d 618 (Del. Ch. 2013), Bloodhound's founder and its four earliest employees watched a series of self-interested insider financings dilute them below 1%. When the company sold for $82.5 million, they collectively [received less than $36,000](https://law.justia.com/cases/delaware/court-of-chancery/2013/ca-7301-vcl.html). Vice Chancellor Laster let their fiduciary duty claims proceed past a motion to dismiss.
The defense is process, and process takes time you will not have once cash gets tight: an independent committee, a genuine market check, contemporaneous documentation of why these terms were the best available, and a valuation from someone with no stake in the answer. Getting the 409A from a firm your lead investor does not control is not a formality here. It is the exhibit.
Where to land
A pay-to-play recap is three transactions sharing one signature page: a financing, a cap table restructuring, and a valuation event. Only the first appears on the term sheet. The preference relief is real, and it is usually smaller than the share count damage. What comes out the other side turns less on the recap price than on whether your appraiser can treat that price as arm's length, and a founder who sees that can raise it while the report is being scoped instead of arguing about the answer once it is written.
If your recap closes this quarter, order the [409A valuation](https://www.409.ai/products/409a) the week the round signs, not the week your next hire asks what their strike price is.